Skip to main content
. 2020 Sep 29;35(1):e23578. doi: 10.1002/jcla.23578

Figure 2.

Figure 2

MiR‐488 expression was associated with malignant symptoms of colorectal cancer (CRC) patients. A, MiR‐488 expression was measured among CRC patients of different tumor sizes, differentiation degrees, infiltration depths, and Duke stages. *: P < .05. B, Receiver operating characteristic (ROC) curves were devised to evaluate the value of miR‐488 in discriminating CRC patients with different tumor sizes, differentiation degrees, infiltration depths, and Duke stages